Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors

Abstract Background Graft-versus-host disease (GVHD) remains a major contributor to mortality and morbidity after allogeneic stem-cell transplantation (allo-HSCT). The updated recommendations suggest that rabbit antithymocyte globulin or anti-T-lymphocyte globulin (ATG) should be used for GVHD proph...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Eolia Brissot, Myriam Labopin, Ian Moiseev, J. J. Cornelissen, Ellen Meijer, Gwendolyn Van Gorkom, Montserrat Rovira, Fabio Ciceri, Laimonas Griskevicius, Didier Blaise, Edouard Forcade, Martin Mistrik, Stephan Mielke, Claude Eric Bulabois, Riitta Niittyvuopio, Eric Deconinck, Annalisa Ruggeri, Jaime Sanz, Alexandros Spyridonidis, Bipin Savani, Sebastian Giebel, Arnon Nagler, Mohamad Mohty
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2020-07-01
Serie:	Journal of Hematology & Oncology
Soggetti:	Post-transplant cyclophosphamide Antithymocyte globulin Matched unrelated donor Acute myeloid leukemia
Accesso online:	http://link.springer.com/article/10.1186/s13045-020-00923-0
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!